Minimize Uncertainty – Make Informed Decisions – Succeed

Respiratory

Respiratory Today—November 28, 2025

November 28, 2025cystic fibrosis,gsk,COPD,BioPharma and Tech News,phage therapy,Tezepelumab,pulmonary arterial hypertension,Respiratory News,severe asthmaInhibikase Therapeutics,Glenmark Pharmaceuticals

Explore this week’s respiratory highlights, including new developments,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Waker BioScience Series A in CGT

November 28, 2025market access,Regulatory,cell and gene therapy,EMA,FDA guidance,biopharma,Lucid Diligence Brief,diligence,CRO services,CLIA CAPintegration site analysis

Lucid Diligence Brief: Waker BioScience Series A in CGT Professional audiences…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—November 27, 2025

November 27, 2025novartis,BioPharma and Tech News,NHS,BMS,Cell and Gene Therapy News,SR Tiget,Sarepta,AutolusFondazione Telethon,Arrowhead

This biweekly Cell and Gene Therapy video reacap covers major regulatory…

by LucidQuest

Rare Disease news

Rare Disease Today—November 27, 2025

November 27, 2025novartis,BioPharma and Tech News,SMA,EMD Serono,Rare Disease News,Applied Therapeutics,generalized myasthenia gravis,CLN3 Batten disease,galactosemia,Itvismacladribine capsules,newborn genomic screening

This week’s rare diseases update spotlights key developments, regulatory…

by LucidQuest

Cardiovascular

Cardiovascular Today—November 27, 2025

November 27, 2025BioPharma and Tech News,HEART FAILURETirzepatide,pulmonary hypertension,Philips,Edwards Lifesciences,Evolocumab,Cardiovascular News,mitral TEER,Atherosclerotic cardiovascular disease,TCT,ESC Digital & AI Summit

Stay informed with this week’s cardiology roundup, featuring key advancements,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Phrontline Biopharma $60m Pre-A+

November 27, 2025Oncology,clinical trials,market access,biopharma,CMC,Lucid Diligence Brief,payer access,diligence,venture financing,competitive landscape,antibody-drug conjugates,partnershipsChina biotech

Lucid Diligence Brief: Phrontline Biopharma $60m Pre-A+ Professional audiences…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Sword Health partners with Greece on AI health "front door"

November 26, 2025digital health,Europe,market access,Regulatory,AI in healthcare,public health,biopharma,Lucid Diligence Brief,payer access,diligence,contact centertriage

Lucid Diligence Brief: Sword Health partners with Greece on AI health "front…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Today—November 27, 2025

November 26, 2025Genprex,Autolus,novartis,Spinal Muscular Atrophy,BioPharma and Tech News,BMS,GEMMABio,Cellectis,Cell and Gene Therapy News,antibody-drug conjugates,Blinatumomab,Sarepta,Aspen Neuroscience,Moligo TechnologiesAGC Biologics,AAVantgarde

This week's Cell and Gene therapy update covers major regulatory approvals,…

by LucidQuest

Immunology

Immunology Today—November 26, 2025

November 26, 2025biologics,sanofi,BioPharma and Tech News,autoimmune diseases,Crohns Disease,Biogen,Regeneron,upadacitinib,Immunology News,Dupixentchronic spontaneous urticaria,antiphospholipid syndrome

This week’s Immunology update spotlights key developments, regulatory…

by LucidQuest

Women's_Health

Women’s Health Video Recap—November 26, 2025

November 26, 2025Sword Health,FamilyWell Health,roche,HPV infection,breast cancer,Mental health disorders,BioPharma and Tech News,Perimenopause,Ovarian Cancer,cervical cancer,menopause,Women's Health News,PAHO,inflammatory bowel disease,IARC,Dialectic Therapeutics,OCRAMillie,Maia AI

This biweekly women’s health video covers major regulatory shifts, coverage…

by LucidQuest

Neuroscience

Neuroscience Video Recap—November 26, 2025

November 26, 2025migraine,multiple sclerosis,Alzheimer's Disease,BioPharma and Tech News,Neurofibromatosis Type 1,Neuroscience News,Leptomeningeal metastasesProgressive multifocal leukoencephalopathy,Plexiform neurofibromas

This biweekly Neuroscience video recap covers regulatory decisions, regional…

by LucidQuest

Neuroscience

Neuroscience Today — November 26, 2025

November 26, 2025Alzheimer's Disease,semaglutide,BioPharma and Tech News,Novo Nordisk,Johnson & Johnson,Selumetinib,Alexion,Neurofibromatosis Type 1,AI drug discovery,Neuroscience Newsmyotonic dystrophy type 1,Leptomeningeal metastases

This week’s Neuroscience news brings you the most important developments,…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.